- Price basis
- As-low-as headline; complete invoice not established
- Vial details
- Confirm concentration, volume and pharmacy
- Recurring terms
- Confirm whether subscription is selected and when it renews
The NAD+ card is the starting point
Velvet Rx identifies NAD+ injection as a separate treatment on its homepage and attaches an as-low-as $89 price. The card does not establish a complete vial specification or the period covered by that figure. We therefore describe it as an advertised starting offer rather than a verified monthly or one-time package price.
The review is specific to NAD+. Prices, promotional reductions and patient stories elsewhere on the homepage may concern weight-management products, so they should not be imported into the NAD+ assessment. A shared storefront does not establish that every product has the same initial charge, renewal conditions or evidence of benefit.
Turn the headline into an itemized quote
Ask which supply and purchase conditions make the $89 offer available. The response should identify the amount due immediately, the quantity supplied and the timing and amount of another charge. An inexpensive starting number becomes useful for comparison only when its denominator is known, whether that is a vial, a period of care or another defined package.
Also confirm whether consultation, supplies, shipping and ongoing clinical support are included. The general terms discuss possible shipping and processing fees, without establishing which apply to this particular order. A complete quote should resolve that issue before the reader treats $89 as the entire financial commitment or assigns zero to every unnamed cost.
Recurring billing needs a clear stopping point
Velvet's public terms explain that selected subscription services renew automatically and that the relevant interval is disclosed at checkout. That makes the checkout agreement important even when the product card itself is brief. Request the renewal date and cancellation method in a form that can be retained with the order confirmation.
Canceling a future charge and obtaining a refund for an already provided service are separate matters. Ask when the prescription is sent for fulfillment and how a change in the clinical plan affects an order at that stage. We have not completed a purchase or tested the company's handling of cancellations, refunds or product concerns.
The exact preparation and purpose still matter
Before fulfillment, identify the clinician, dispensing pharmacy, concentration, volume and storage requirements of the proposed injection. The site describes a clinical-access model, but we did not verify an independent study of this finished preparation or establish the advertised energy and healthy-aging outcomes for a particular patient.
Compounded NAD+ does not acquire FDA approval from general approval language elsewhere on a provider's website. The clinician should explain the relevant evidence and uncertainties for the intended use, alongside any individual suitability issues. This product review preserves a documented $89 starting point while making clear which information is still needed for a meaningful price and care comparison; it does not use the headline to imply clinical superiority.
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.